| An Add-On Trial of Quetiapine in Patients With Bipolar Disorder and Cocaine Dependence (NCT00223210) | University of Texas Southwestern Medical Center | 2005-11-01 |
| Treatment of Bipolar Mania in Older Adults (NCT00254488) | Weill Medical College of Cornell University | 2005-11-01 |
| Bipolar Disorder in Late Life (NCT00787930) | Duke University | 2005-10-01 |
| Cognitive Enhancement in Bipolar Disorder (NCT00597896) | Northwell Health | 2005-10-01 |
| To Demonstrate the Relative Bioavailability of Divalproex Sodium 500 mg Delayed Release Tablets Under Fed Conditions (NCT00913848) | Sandoz | 2005-10-01 |
| Sleep Deprivation and Advancement of Sleep Period as Treatment for Bipolar Depression. (NCT00229151) | Norwegian University of Science and Technology | 2005-10-01 |
| To Demonstrate the Relative Bioavailability of Divalproex Sodium 500 mg Delayed Release Tablets Under Fasting Conditions (NCT00913874) | Sandoz | 2005-10-01 |
| An Open-Label Extension Study Of Lamotrigine In Subjects With Bipolar Disorder (NCT00360126) | GlaxoSmithKline | 2005-10-01 |
| Genetic Predictors of Lithium Response in Bipolar Disorder (NCT00252577) | VA Office of Research and Development | 2005-10-01 |
| Effects of Pentazocine on Manic Symptoms (NCT00125931) | Mclean Hospital | 2005-09-01 |
| Decreasing Risk of Coronary Artery Disease in Schizophrenia by Omega-3 Fatty Acid Supplementation (NCT00167310) | University of Pittsburgh | 2005-09-01 |
| White Matter in Pediatric Bipolar Disorder: A DTI Study (NCT00391235) | Cambridge Health Alliance | 2005-09-01 |
| A Study of Aripiprazole (Abilify) in Patients With Bipolar Mania (NCT00261443) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2005-09-01 |
| Effects of Psycho-education of Patients With Bipolar Disorder (NCT00159562) | Norwegian University of Science and Technology | 2005-09-01 |
| Ropinirole in the Treatment of Bipolar Depression (NCT00314821) | Cambridge Health Alliance | 2005-09-01 |
| Efficacy and Safety of Seroquel and Lithium as Monotherapy in Acute Mania Treatment in Bipolar Disorder Patients (NCT00448578) | AstraZeneca | 2005-08-01 |
| Identifying Predictors of Bipolar Disorder Relapse During Pregnancy and the Postpartum Period (NCT00720395) | National Institute of Mental Health (NIMH) | 2005-08-01 |
| 40 Week Trial to Study the Safety of Asenapine When Added to Lithium or Valproate in the Treatment of Bipolar Disorder (A7501009)(P05786) (NCT00145509) | Organon and Co | 2005-08-01 |
| Family Workshops for Bipolar Disorder (NCT00296283) | University of Miami | 2005-08-01 |
| Seroquel in Bipolar Depression Versus Lithium (NCT00206141) | AstraZeneca | 2005-08-01 |
| Aripiprazole Associated With Methylphenidate in Children and Adolescents With Bipolar Disorder and ADHD (NCT00305370) | Federal University of Rio Grande do Sul | 2005-08-01 |
| Lamictal As Add on Treatment in Mixed States of Bipolar Disorder (NCT00223509) | The University of Texas Health Science Center at San Antonio | 2005-08-01 |
| Recovery Group Pilot (NCT00522613) | Kaiser Permanente | 2005-07-01 |
| Seroquel in Acute Mania: Study to Investigate if Valproate Add-On Therapy is Superior to Quetiapine Monotherapy in Acutely Manic Patients (NCT00139074) | AstraZeneca | 2005-07-01 |
| Short Term Rescue Study of Olanzapine (NCT00186017) | Stanford University | 2005-07-01 |
| 40 Week Extension Study Of Asenapine and Olanzapine For Bipolar Disorder (A7501007)(COMPLETED)(P05857) (NCT00159783) | Organon and Co | 2005-07-01 |
| Equetro for the Treatment of Mania in Children Ages 6-12 With Bipolar Disorder (NCT00181870) | Massachusetts General Hospital | 2005-07-01 |
| A Six-Week Study Evaluating The Efficacy And Safety Of Geodon In Patients With A Diagnosis Of Bipolar I Depression (NCT00141271) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2005-07-01 |
| AIMHI NT Relapse Prevention Trial (NCT00192582) | Menzies School of Health Research | 2005-07-01 |
| Trial of Olanzapine in Patients With Manic or Mixed Episode of Bipolar I Disorder (NCT00129220) | Eli Lilly and Company | 2005-07-01 |
| Dopamine Receptor Imaging in Mood Disorders (NCT00116077) | National Institute of Mental Health (NIMH) | 2005-06-21 |
| Study Evaluating Bifeprunox in Bipolar Depression (NCT00134459) | Wyeth is now a wholly owned subsidiary of Pfizer | 2005-06-01 |
| A Non-Interventional Post-Marketing Surveillance Study to Evaluate the Safety and Efficacy of Zeldox Capsule (NCT01053429) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2005-06-01 |
| Olanzapine Treated Adolescents With Schizophrenia or Bipolar I Disorder (NCT00113594) | Eli Lilly and Company | 2005-06-01 |
| A Brief Community Linkage Intervention for Dually Diagnosed Individuals (NCT00137267) | US Department of Veterans Affairs | 2005-06-01 |
| ADH.E.R.E.: Therapeutic ADHerence and Treatment Strategies: A Mental Health Registry (NCT00264069) | Janssen-Cilag, S.A. | 2005-06-01 |
| An Open-Label Trial of Aripiprazole in Children and Adolescents With Bipolar Disorder (NCT00221416) | University of Cincinnati | 2005-06-01 |
| Bipolar Disorder (BPD) in Pregnancy: Predictors of Morbidity (NCT00864370) | Emory University | 2005-05-01 |
| The Efficacy and Safety of AChE Inhibitor Donepezil As Adjunctive Treatment to Mood Stabilizers in Acute Mania (NCT01191918) | Shanghai Mental Health Center | 2005-05-01 |
| Seroquel in Bipolar Depression Versus SSRI (NCT00119652) | AstraZeneca | 2005-05-01 |
| Naltrexone for Bipolar Disorder and Alcohol Dependence (NCT00223275) | University of Texas Southwestern Medical Center | 2005-05-01 |
| Clinical Trial of a Nutritional Supplement in Adults With Bipolar Disorder (NCT00109577) | University of Calgary | 2005-04-01 |
| Taurine as an Anti-Manic Agent: A Double-Blind, Placebo-Controlled Study (NCT00217165) | Mclean Hospital | 2005-04-01 |
| Aripiprazole in Children and Adolescents With Bipolar I Disorder (NCT00110461) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2005-03-01 |
| Effects of a Lifestyle Intervention on Body Mass Index in Patients With Bipolar Disorder (NCT00980863) | University of Zurich | 2005-03-01 |
| Aripiprazole in Children and Adolescents With Bipolar Disorder and Attention Deficit Hyperactivity Disorder (ADHD) (NCT00116259) | Federal University of Rio Grande do Sul | 2005-03-01 |
| Abilify Therapy for Reducing Comorbid Substance Abuse (NCT00208169) | Creighton University | 2005-03-01 |
| Quetiapine Fumarate Bipolar Maintenance Monotherapy (NCT00314184) | AstraZeneca | 2005-03-01 |
| Safety of SPD417 Combined With Other Psychotropic Medications in the Treatment of Bipolar I Disorder (NCT00150605) | Validus Pharmaceuticals | 2005-02-01 |
| Quetiapine for Mania In Preschool Children 4 to 6 Years of Age With Bipolar Disorder (NCT00181883) | Massachusetts General Hospital | 2005-02-01 |
| An Evaluation of the Safety and Efficacy of Memantine in Patients With Acute Mania Associated With Bipolar I Disorder (NCT00106405) | Forest Laboratories | 2005-02-01 |
| Treatment of Mania Symptoms With Drug Therapy (NCT00183443) | Palo Alto Veterans Institute for Research | 2005-02-01 |
| A Study of the Safety and Efficacy of Injectable Risperidone in the Prevention of Bipolar Mood Episodes (NCT00132678) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2005-02-01 |
| 9 Week Extension Study of Asenapine and Olanzapine in Treatment of Mania (P07007)(COMPLETED) (NCT00143182) | Organon and Co | 2005-01-07 |
| Bupropion SR for Major Depression and Depression NOS in Children and Adolescents With Bipolar Disorder (NCT00181896) | Massachusetts General Hospital | 2005-01-01 |
| Safety Study of Sodium Divalproate in Bipolar Disorder in Adolescents (NCT00271258) | Sanofi | 2005-01-01 |
| Lamotrigine for the Treatment of Mania in Youth Ages 6-17 With Bipolar Disorder (NCT00181844) | Massachusetts General Hospital | 2005-01-01 |
| Efficacy and Safety of SPD417 in Treatment of Manic Symptoms in Adults With Bipolar I Disorder (NCT00150553) | Validus Pharmaceuticals | 2005-01-01 |
| The Immune System and Psychiatric Disorders (NCT00184418) | Norwegian University of Science and Technology | 2005-01-01 |
| 3-week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07009) (NCT00159796) | Organon and Co | 2004-12-14 |
| Study of Aripiprazole in Patients With Acute Bipolar Mania (NCT00097266) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2004-12-01 |
| Open Label Extension Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder (NCT00139594) | Novartis | 2004-12-01 |
| Valproic Acid Sodium Salt in Bipolar Disorder (NCT00431522) | Sanofi | 2004-12-01 |
| Maintenance Treatment of Bipolar Depression (NCT00183469) | The University of Texas Health Science Center at San Antonio | 2004-12-01 |
| 3-Week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07008) (NCT00159744) | Organon and Co | 2004-11-30 |
| Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder (NCT00099229) | Novartis Pharmaceuticals | 2004-11-01 |
| Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder (NCT00107939) | Novartis Pharmaceuticals | 2004-11-01 |
| Olanzapine vs. Comparator and Placebo in the Treatment of Patients With Bipolar I Disorder (NCT00094549) | Eli Lilly and Company | 2004-10-01 |
| Study Measuring Differences in Cognition Due to Sedative Effects of Risperidone and Quetiapine in Stable Bipolar I Outpatients (NCT00097032) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2004-10-01 |
| Study of Aripiprazole in Patients With Bipolar I Disorder (NCT00257972) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2004-10-01 |
| A Study in the Treatment of Acute Mania (NCT00767715) | Eli Lilly and Company | 2004-10-01 |
| Optimal Length of Treatment Continuation With Olanzapine After Remission of Manic or Mixed Episode (NCT00191997) | Eli Lilly and Company | 2004-10-01 |
| The Safety and Efficacy of Risperidone as Adjunctive Therapy to Mood Stabilizers in the Long-term Treatment of Bipolar Mania (NCT00216554) | Janssen Korea, Ltd., Korea | 2004-09-01 |
| Placebo Controlled Trial of Valproate and Risperidone in Young Children With Bipolar Disorders (NCT00221403) | Children's Hospital Medical Center, Cincinnati | 2004-09-01 |
| Olanzapine Plus Carbamazepine in the Treatment of Bipolar I Mania (NCT00190892) | Eli Lilly and Company | 2004-09-01 |
| Aripiprazole Open-Label, Safety and Tolerability Study (NCT00102518) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2004-09-01 |
| 12- Week Open Label Treatment of Refractory Bipolar Depression (NCT00223496) | The University of Texas Health Science Center at San Antonio | 2004-09-01 |
| Low Field Magnetic Stimulation Treatment for Bipolar Depression (NCT00217217) | Mclean Hospital | 2004-09-01 |
| Study of Aripiprazole (Abilify) in Children With Symptoms of Mania (NCT00194077) | University Hospitals Cleveland Medical Center | 2004-08-01 |
| Study of Aripiprazole (Abilify) Versus Placebo in Children With Subsyndromal Bipolar Disorder (NCT00194012) | University Hospitals Cleveland Medical Center | 2004-08-01 |
| Understanding Treatment Adherence Among Individuals With Rapid Cycling Bipolar Disorder (NCT00183703) | Case Western Reserve University | 2004-07-01 |
| Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Children & Adolescents With Bipolar I Mania (NCT00090311) | AstraZeneca | 2004-07-01 |
| Cytidine and Omega-3 Fatty Acids in Bipolar Disorder (NCT00854737) | Mclean Hospital | 2004-07-01 |
| Quetiapine (Seroquel) Maintenance Treatment in Early Onset Bipolar Spectrum Disorders (NCT00252226) | Mood Disorders Center of Ottawa | 2004-06-01 |
| Controlled Study of the Use of Quetiapine Fumarate in the Treatment of Patients With Bipolar Depression (NCT00083954) | AstraZeneca | 2004-06-01 |
| Risk Factors for Development of Rapid Cycling in Bipolar Disorder Patients (NCT01992302) | Hospital Clinic of Barcelona | 2004-06-01 |
| Aripiprazole in Patients With Acute Mania (NCT00095511) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2004-06-01 |
| A Study of Effectiveness and Safety of Risperdal CONSTA Added to Usual Treatment in Patients With Bipolar Disorder Who Have Frequent Mood Episodes. (NCT00094926) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2004-05-01 |
| SOLMANIA - Comparison of Valproate-Amisulpride and Valproate-Haloperidol in Bipolar I Patients (NCT00126009) | Sanofi | 2004-05-01 |
| A Double-Blind Placebo Controlled Trial of Riluzole in Bipolar Depression (NCT00376220) | Johns Hopkins University | 2004-05-01 |
| Behavioral Processes Underlying Reward Processing in Depression (NCT00205933) | Affective Neuroscience Laboratory | 2004-04-01 |
| A Preliminary Study of Sustained-Release Bupropion for Smoking Cessation in Bipolar Affective Disorder (NCT00593099) | National Institute on Drug Abuse (NIDA) | 2004-04-01 |
| Aripiprazole in the Treatment of Bipolar Depression (NCT00226317) | Cambridge Health Alliance | 2004-04-01 |
| Aripiprazole in Late Life Bipolar Disorder (NCT00194038) | University Hospitals Cleveland Medical Center | 2004-04-01 |
| Psychiatric Advance Directives for Improved Mental Health Care (NCT00105794) | US Department of Veterans Affairs | 2004-03-01 |
| The Effects of Aripiprazole on Patients With Metabolic Syndrome (NCT00224822) | New Mexico VA Healthcare System | 2004-03-01 |
| Supraphysiological Doses of Levothyroxine as Adjunctive Therapy in Bipolar Depression (NCT01528839) | Charite University, Berlin, Germany | 2004-03-01 |
| Efficacy and Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder (NCT00081380) | AstraZeneca | 2004-03-01 |
| Understanding Treatment Adherence Among Individuals With Bipolar Disorder (NCT00183495) | Case Western Reserve University | 2004-03-01 |
| Study of Quetiapine Monotherapy in Ambulatory Bipolar Spectrum Disorder With Moderate-to-Severe Hypomanic Symptoms or Mild Manic Symptoms (NCT00277667) | Lindner Center of HOPE | 2004-02-01 |